Labetalol hydrochloride and Cardiac failure congestive - a phase IV clinical study of FDA data

Summary:

Cardiac failure congestive is reported as a side effect among people who take Labetalol hydrochloride (labetalol hydrochloride), especially for people who are male, 60+ old, also take Plavix, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Cardiac failure congestive when taking Labetalol hydrochloride. It is created by eHealthMe based on reports of 1,981 people who have side effects when taking Labetalol hydrochloride from the FDA, and is updated regularly.

What is Labetalol hydrochloride?

Labetalol hydrochloride has active ingredients of labetalol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 2,413 Labetalol hydrochloride users. Check the latest studies of Labetalol hydrochloride.

What is Cardiac failure congestive?

Cardiac failure congestive is found to be associated with 2,152 drugs and 2,144 conditions by eHealthMe. Check the latest studies of Cardiac failure congestive.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

1,981 people reported to have side effects when taking Labetalol hydrochloride.
Among them, 13 people (0.66%) have Cardiac failure congestive.

Could Labetalol hydrochloride cause Cardiac failure congestive?

Among these 13 people:

What is the gender of people who have Cardiac failure congestive when taking Labetalol hydrochloride? *

female: 50 %
male: 50 %

What is the age of people who have Cardiac failure congestive when taking Labetalol hydrochloride? *

What are other drugs people take besides Labetalol hydrochloride? *

What are other side effects people have besides Cardiac failure congestive? *

Nausea (feeling of having an urge to vomit): 7 people, 53.85%
Fatigue (feeling of tiredness): 6 people, 46.15%
Heart Attack: 6 people, 46.15%
Pleural Effusion (water on the lungs): 5 people, 38.46%
Nausea And Vomiting: 5 people, 38.46%
Pulmonary Oedema (fluid accumulation in the lungs): 5 people, 38.46%
Dyspnea (difficult or laboured breathing): 5 people, 38.46%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 5 people, 38.46%
Arrhythmias (irregular heartbeat): 4 people, 30.77%
Pneumonia: 4 people, 30.77%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 15.38%
Type 2 Diabetes: 1 person, 7.69%
Stress And Anxiety: 1 person, 7.69%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 1 person, 7.69%
Alcoholism (problems with alcohol): 1 person, 7.69%
Cardiac Disorder: 1 person, 7.69%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 7.69%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 7.69%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 7.69%
Diabetes: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Labetalol hydrochloride and have Cardiac failure congestive?

- Check whether Cardiac failure congestive is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Labetalol hydrochloride:

Labetalol hydrochloride (2,413 reports)

Browse all side effects of Labetalol hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardiac failure congestive:

Cardiac failure congestive (2,152 drugs)

Browse all the conditions that are associated with Cardiac failure congestive:

Cardiac failure congestive (2,144 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on labetalol hydrochloride (the active ingredients of Labetalol hydrochloride) and Labetalol hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.